HDAC6/HSP90-IN-3

HDAC6/HSP90-IN-3 (Compound 17) is an orally active dual histone deacetylase 6 (HDAC6) and heat shock protein 90 (HSP90) inhibitor with IC50 values of 28 nM and 0.88 μM, respectively. HDAC6/HSP90-IN-3 is promising for research of malignant tumors such as prostate cancer[1].

Product Specifications

UNSPSC

12352005

Target

HDAC; HSP

Related Pathways

Cell Cycle/DNA Damage; Epigenetics; Metabolic Enzyme/Protease

Field of Research

Cancer

Smiles

CC1=CN=C(CN2C3=NC(N)=NC(Cl)=C3C(CC4=CC=C(C(NO)=O)C=C4)=C2)C(C)=C1OC

Molecular Formula

C23H23ClN6O3

Molecular Weight

466.92

References & Citations

[1]Citarella A, et al. Structure-Based Discovery of Hsp90/HDAC6 Dual Inhibitors Targeting Aggressive Prostate Cancer. J Med Chem. 2025 Aug 14;68 (15) :15738-15765.